Transfection

Transfection of physiologically relevant primary cells or stem cells is typically a very difficult task using traditional transfection methods. Additionally, when using relevant cell lines as model systems, the critical issues are to achieve reproducibly efficient transfection with high levels of viability while matching throughput capability required at each project phase – from proof of concept, through to scale-up and screening-like approaches.

With the electroporation-based Nucleofector™ Technology primary cells and stem cells, as well as cell lines, can be consistently transfected at high efficiency. Developed in 1998, Nucleofection™ has evolved through continuous innovation into a comprehensive portfolio of devices and kits for many different transfection needs. 

Transfection Publications with Amaxa™ Nucleofector™ Technology 

Download our list of selected Nucleofector™ Publications focusing on immunology, neurobiology, reprogramming and genome editing.

 Transfection Accessories

• Cells on Demand Transfection Services – Available for those missing the resources or expertise to do transfection in their lab
• Nucleofector™ PLUS Supplements – For generation of cryopreserved Nucleofection™ competent cells
• Optimized Mouse T Cell Medium  – Specialized media for post Nucleofection™ Culture of mouse T cells
• pmaxCloning™ Vector  – Promotes strong, constitutive expression of cloned DNA inserts in mammalian cells